Found: 15
Select item for more details and to access through your institution.
Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study.
- Published in:
- PLoS Medicine, 2023, v. 19, n. 6, p. 1, doi. 10.1371/journal.pmed.1004157
- By:
- Publication type:
- Article
cGMP production and analysis of BG505 SOSIP.664, an extensively glycosylated, trimeric HIV‐1 envelope glycoprotein vaccine candidate.
- Published in:
- Biotechnology & Bioengineering, 2018, v. 115, n. 4, p. 885, doi. 10.1002/bit.26498
- By:
- Publication type:
- Article
Predictors of Nonseroconversion after SARS-CoV-2 Infection.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Antibody potency relates to the ability to recognize the closed, pre-fusion form of HIV Env.
- Published in:
- Nature Communications, 2015, v. 6, n. 2, p. 6144, doi. 10.1038/ncomms7144
- By:
- Publication type:
- Article
Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C.
- Published in:
- PLoS Pathogens, 2016, v. 12, n. 9, p. 1, doi. 10.1371/journal.ppat.1005864
- By:
- Publication type:
- Article
Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer.
- Published in:
- PLoS Pathogens, 2015, v. 11, n. 3, p. 1, doi. 10.1371/journal.ppat.1004767
- By:
- Publication type:
- Article
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies.
- Published in:
- PLoS Pathogens, 2013, v. 9, n. 9, p. 1, doi. 10.1371/journal.ppat.1003618
- By:
- Publication type:
- Article
Broadly Neutralizing Antibody PGT121 Allosterically Modulates CD4 Binding via Recognition of the HIV-1 gp120 V3 Base and Multiple Surrounding Glycans
- Published in:
- PLoS Pathogens, 2013, v. 9, n. 5, p. 1, doi. 10.1371/journal.ppat.1003342
- By:
- Publication type:
- Article
Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits.
- Published in:
- Retrovirology, 2014, v. 11, n. 1, p. 1, doi. 10.1186/1742-4690-11-41
- By:
- Publication type:
- Article
Stable 293 T and CHO cell lines expressing cleaved, stable HIV-1 envelope glycoprotein trimers for structural and vaccine studies.
- Published in:
- Retrovirology, 2014, v. 11, n. 1, p. 1, doi. 10.1186/1742-4690-11-33
- By:
- Publication type:
- Article
Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120.
- Published in:
- Nature Structural & Molecular Biology, 2013, v. 20, n. 7, p. 796, doi. 10.1038/nsmb.2594
- By:
- Publication type:
- Article
Correction: HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.
- Published in:
- Nature, 2014, v. 509, n. 7498, p. 55, doi. 10.1038/nature13036
- By:
- Publication type:
- Article
HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers.
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0181886
- By:
- Publication type:
- Article
Optimizing the production and affinity purification of HIV-1 envelope glycoprotein SOSIP trimers from transiently transfected CHO cells.
- Published in:
- PLoS ONE, 2019, v. 14, n. 4, p. 1, doi. 10.1371/journal.pone.0215106
- By:
- Publication type:
- Article